BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27008797)

  • 1. STABILITY OF CEFPIROME SULFATE IN AQUEOUS SOLUTIONS.
    Zalewski P; Jelińska A; Paczkowska M; Garbacki P; Talaczyńska A; Stfpniak P; Cielecka-Piontek J
    Acta Pol Pharm; 2016; 73(1):23-7. PubMed ID: 27008797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of cefozopran hydrochloride in aqueous solutions.
    Zalewski P; Skibiński R; Paczkowska M; Garbacki P; Talaczyńska A; Cielecka-Piontek J; Jelińska A
    Drug Dev Ind Pharm; 2016; 42(4):572-7. PubMed ID: 26079426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid-base catalysis of N-[(morpholine)methylene]daunorubicin.
    Krause A; Jelińska A; Cielecka-Piontek J; Klawitter M; Zalewski P; Oszczapowicz I; Wąsowska M
    Drug Dev Ind Pharm; 2012 Aug; 38(8):1024-8. PubMed ID: 22124459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of ertapenem in aqueous solutions.
    Zajac M; Cielecka-Piontek J; Jelińska A
    J Pharm Biomed Anal; 2007 Jan; 43(2):445-9. PubMed ID: 16914282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of hydrolysis of ceftazidime in aqueous solutions.
    Siwek J; Zajac M
    Acta Pol Pharm; 1995; 52(1):21-30. PubMed ID: 8984847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of pH, temperature and buffers on the degradation kinetics of cefetamet pivoxil hydrochloride in aqueous solutions.
    Jelińska A; Dobrowolski L; Oszczapowicz I
    J Pharm Biomed Anal; 2004 Sep; 35(5):1273-7. PubMed ID: 15336372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced stability of codeine sulfate: effect of pH, buffer, and temperature on the degradation of codeine in aqueous solution.
    Powell MF
    J Pharm Sci; 1986 Sep; 75(9):901-3. PubMed ID: 3783462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of cefpirome sulfate in the presence of commonly used intensive care drugs during simulated Y-site injection.
    Allen LV; Stiles ML; Prince SJ; Sylvestri MF
    Am J Health Syst Pharm; 1995 Nov; 52(21):2427-33. PubMed ID: 8564608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of stability-indicating HPLC method for determination of cefpirome sulfate.
    Zalewski P; Skibiński R; Cielecka-Piontek J; Bednarek-Rajewska K
    Acta Pol Pharm; 2014; 71(5):731-6. PubMed ID: 25362801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability studies of cefpirome sulfate in the solid state: Identification of degradation products.
    Zalewski P; Skibiński R; Cielecka-Piontek J
    J Pharm Biomed Anal; 2014 Apr; 92():22-5. PubMed ID: 24469097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability and degradation pattern of cefpirome (HR 810) in aqueous solution.
    Sugioka T; Asano T; Chikaraishi Y; Suzuki E; Sano A; Kuriki T; Shirotsuka M; Saito K
    Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):1998-2002. PubMed ID: 2268903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutions.
    Fubara JO; Notari RE
    J Pharm Sci; 1998 Dec; 87(12):1572-6. PubMed ID: 10189269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics and mechanism of the base-catalyzed rearrangement and hydrolysis of ezetimibe.
    Baťová J; Imramovský A; HájÍček J; Hejtmánková L; Hanusek J
    J Pharm Sci; 2014 Aug; 103(8):2240-7. PubMed ID: 24985565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the ion pair concept to the n-octanol-water partitioning of cefepime and cefpirome.
    Koufopoulou SA; Pistos C; Giaginis C; Tsantili-Kakoulidou A
    Int J Pharm; 2006 Jun; 316(1-2):52-7. PubMed ID: 16564653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefuroxime hydrolysis kinetics and stability predictions in aqueous solution.
    Wang D; Notari RE
    J Pharm Sci; 1994 Apr; 83(4):577-81. PubMed ID: 8046618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. La3+-catalyzed methanolysis of N-aryl-beta-lactams and nitrocefin.
    Montoya-Pelaez PJ; Gibson GT; Neverov AA; Brown RS
    Inorg Chem; 2003 Dec; 42(26):8624-32. PubMed ID: 14686838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of hydrolysis of 4-methoxy-2-[2-hydroxy-3(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]pyridine in aqueous solutions.
    Muszalska I
    Farmaco; 2004 Jun; 59(6):437-42. PubMed ID: 15178305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.
    Denora N; Potts BC; Stella VJ
    J Pharm Sci; 2007 Aug; 96(8):2037-47. PubMed ID: 17554770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pH, temperature, and buffers on the kinetics of ceftazidime degradation in aqueous solutions.
    Zhou M; Notari RE
    J Pharm Sci; 1995 May; 84(5):534-8. PubMed ID: 7658340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation and characterization of impurities and isomers in cefpirome sulfate by liquid chromatography/tandem mass spectrometry and a summary of the fragmentation pathways of oxime-type cephalosporins.
    Ren X; Zhou J; Wang J
    Rapid Commun Mass Spectrom; 2021 Feb; 35(4):e9004. PubMed ID: 33188542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.